Abstract
Hypoxia and ischemia play a major role in the pathogenesis of cerebrovascular diseases such as stroke. However, the protective strategies against hypoxic and ischemic insults are very limited in clinical settings. This has reinforced the need to improve our understanding of the hypoxic and ischemic cascades and explore novel solutions of hypoxic/ ischemic injury. Recent research has identified the crucial role of microRNAs in regulation of gene expression under hypoxic/ischemic conditions. These 19-24 ribonucleotide non-coding RNA molecules function as inhibitory modulators of gene expression, by targeting mRNAs and promoting either RNA degradation or translational repression. They are differentially regulated in the brain as well as other organs under hypoxic and ischemic conditions. Targeting microRNA expression/activity offers a potentially effective way to intervene against hypoxic and ischemic injury. In this review, we highlight recent updates with summary of our recent work, which provides an insight into the roles and mechanisms of microRNA-induced regulation of cellular and molecular processes in response to hypoxic and/or ischemic stress.
Keywords: Brain, heart, hypoxia, ischemia, kidney, microRNAs.
Current Medicinal Chemistry
Title:Effects of Hypoxia and Ischemia on MicroRNAs in the Brain
Volume: 22 Issue: 10
Author(s): Yilin Yang, Harleen K Sandhu, Feng Zhi, Fei Hua, Min Wu and Ying Xia
Affiliation:
Keywords: Brain, heart, hypoxia, ischemia, kidney, microRNAs.
Abstract: Hypoxia and ischemia play a major role in the pathogenesis of cerebrovascular diseases such as stroke. However, the protective strategies against hypoxic and ischemic insults are very limited in clinical settings. This has reinforced the need to improve our understanding of the hypoxic and ischemic cascades and explore novel solutions of hypoxic/ ischemic injury. Recent research has identified the crucial role of microRNAs in regulation of gene expression under hypoxic/ischemic conditions. These 19-24 ribonucleotide non-coding RNA molecules function as inhibitory modulators of gene expression, by targeting mRNAs and promoting either RNA degradation or translational repression. They are differentially regulated in the brain as well as other organs under hypoxic and ischemic conditions. Targeting microRNA expression/activity offers a potentially effective way to intervene against hypoxic and ischemic injury. In this review, we highlight recent updates with summary of our recent work, which provides an insight into the roles and mechanisms of microRNA-induced regulation of cellular and molecular processes in response to hypoxic and/or ischemic stress.
Export Options
About this article
Cite this article as:
Yang Yilin, Sandhu K Harleen, Zhi Feng, Hua Fei, Wu Min and Xia Ying, Effects of Hypoxia and Ischemia on MicroRNAs in the Brain, Current Medicinal Chemistry 2015; 22 (10) . https://dx.doi.org/10.2174/0929867322666150209154755
DOI https://dx.doi.org/10.2174/0929867322666150209154755 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Calcium and Vitamin D Supplementation. Myths and Realities with Regard to Cardiovascular Risk
Current Vascular Pharmacology Effects of Endothelins on Cardiac and Vascular Cells: New Therapeutic Target for the Future?
Current Vascular Pharmacology Challenges and Perspectives of Antiplatelet Therapy in Patients with Diabetes Mellitus and Coronary Artery Disease
Current Pharmaceutical Design The Effect of Adult and Pediatric Cardiopulmonary Bypass on Pharmacokinetic and Pharmacodynamic Parameters
Current Clinical Pharmacology Emerging Role of Antioxidants in the Protection of Uveitis Complications
Current Medicinal Chemistry Telemonitoring in the Management of High Blood Pressure
Current Pharmaceutical Design Lifestyle Modifications in the Treatment of Hypertension
Current Hypertension Reviews Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Biomarkers for Cardiovascular Surgery Procedures: A Literature Review
Reviews on Recent Clinical Trials Structure-Based Virtual Ligand Screening: Recent Success Stories
Combinatorial Chemistry & High Throughput Screening Rationalizing the Study of Plants for the Treatment of Oral Pain
Current Chemical Biology Prognostic Implications of Genetics in Cardiovascular Disease
Current Pharmacogenomics Synthesis and Anti-tubercular Activity of 6-(<i>4</i>-Chloro/Methyl-phenyl)-4- Arylidene-4,5-dihydropyridazin-3(2<i>H</i>)-one Derivatives Against Mycobacterium tuberculosis
Letters in Drug Design & Discovery Cardiovascular Physiology of Androgens and Androgen Testosterone Therapy in Postmenopausal Women
Endocrine, Metabolic & Immune Disorders - Drug Targets Current Approaches for the Treatment with Thyroid Hormone Analogs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Colorectal Cancer Microenvironment: Among Nutrition, Gut Microbiota, Inflammation and Epigenetics
Current Pharmaceutical Design Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery Prevention and Therapeutic Strategies of Thromboembolic Events in Patients with Inflammatory Bowel Diseases: A Report of Three Cases
Current Drug Targets Sleep-Disordered Breathing and Cardiovascular Disease: Exploring Pathophysiology and Existing Data
Current Respiratory Medicine Reviews MicroRNAs in Organogenesis and Disease
Current Molecular Medicine Vitamin D and Cardiovascular Disease
Current Vascular Pharmacology